BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24674775)

  • 21. Fatty acid composition in the postmortem amygdala of patients with schizophrenia, bipolar disorder, and major depressive disorder.
    Hamazaki K; Hamazaki T; Inadera H
    J Psychiatr Res; 2012 Aug; 46(8):1024-8. PubMed ID: 22572570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced Insulin-Like Growth Factor Family Member Expression Predicts Neurogenesis Marker Expression in the Subependymal Zone in Schizophrenia and Bipolar Disorder.
    Weissleder C; Webster MJ; Barry G; Shannon Weickert C
    Schizophr Bull; 2021 Jul; 47(4):1168-1178. PubMed ID: 33274367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further neuroimaging evidence for the deficit subtype of schizophrenia: a cortical connectomics analysis.
    Wheeler AL; Wessa M; Szeszko PR; Foussias G; Chakravarty MM; Lerch JP; DeRosse P; Remington G; Mulsant BH; Linke J; Malhotra AK; Voineskos AN
    JAMA Psychiatry; 2015 May; 72(5):446-55. PubMed ID: 25786193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCL11B/CTIP2 is highly expressed in GABAergic interneurons of the mouse somatosensory cortex.
    Nikouei K; Muñoz-Manchado AB; Hjerling-Leffler J
    J Chem Neuroanat; 2016 Jan; 71():1-5. PubMed ID: 26698402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression.
    Regenold WT; Phatak P; Marano CM; Gearhart L; Viens CH; Hisley KC
    Psychiatry Res; 2007 Jun; 151(3):179-88. PubMed ID: 17433451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prefrontal gyrification in psychotic bipolar I disorder vs. schizophrenia.
    Nenadic I; Maitra R; Dietzek M; Langbein K; Smesny S; Sauer H; Gaser C
    J Affect Disord; 2015 Oct; 185():104-7. PubMed ID: 26160154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder.
    Rimol LM; Hartberg CB; Nesvåg R; Fennema-Notestine C; Hagler DJ; Pung CJ; Jennings RG; Haukvik UK; Lange E; Nakstad PH; Melle I; Andreassen OA; Dale AM; Agartz I
    Biol Psychiatry; 2010 Jul; 68(1):41-50. PubMed ID: 20609836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders.
    Xing G; Zhang L; Russell S; Post R
    Schizophr Res; 2006 May; 84(1):36-56. PubMed ID: 16631355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
    Beneyto M; Meador-Woodruff JH
    Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZNF804A and cortical thickness in schizophrenia and bipolar disorder.
    Bergmann O; Haukvik UK; Brown AA; Rimol LM; Hartberg CB; Athanasiu L; Melle I; Djurovic S; Andreassen OA; Dale AM; Agartz I
    Psychiatry Res; 2013 May; 212(2):154-7. PubMed ID: 23562677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons.
    Reynolds GP; Beasley CL; Zhang ZJ
    J Neural Transm (Vienna); 2002 May; 109(5-6):881-9. PubMed ID: 12111475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
    Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG
    Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional and imaging-genetic association of cortical interneurons, brain function, and schizophrenia risk.
    Anderson KM; Collins MA; Chin R; Ge T; Rosenberg MD; Holmes AJ
    Nat Commun; 2020 Jun; 11(1):2889. PubMed ID: 32514083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural abnormality in schizophrenia versus bipolar disorder: A whole brain cortical thickness, surface area, volume and gyrification analyses.
    Madre M; Canales-Rodríguez EJ; Fuentes-Claramonte P; Alonso-Lana S; Salgado-Pineda P; Guerrero-Pedraza A; Moro N; Bosque C; Gomar JJ; Ortíz-Gil J; Goikolea JM; Bonnin CM; Vieta E; Sarró S; Maristany T; McKenna PJ; Salvador R; Pomarol-Clotet E
    Neuroimage Clin; 2020; 25():102131. PubMed ID: 31911343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
    Ishikawa M; Mizukami K; Iwakiri M; Asada T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.
    Gray LJ; Dean B; Kronsbein HC; Robinson PJ; Scarr E
    Psychiatry Res; 2010 Jul; 178(2):374-80. PubMed ID: 20488553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive brain changes in children and adolescents with first-episode psychosis.
    Arango C; Rapado-Castro M; Reig S; Castro-Fornieles J; González-Pinto A; Otero S; Baeza I; Moreno C; Graell M; Janssen J; Parellada M; Moreno D; Bargalló N; Desco M
    Arch Gen Psychiatry; 2012 Jan; 69(1):16-26. PubMed ID: 22213785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder.
    Sakai T; Oshima A; Nozaki Y; Ida I; Haga C; Akiyama H; Nakazato Y; Mikuni M
    Neuropathology; 2008 Apr; 28(2):143-50. PubMed ID: 18069969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular pathology in the dorsolateral prefrontal cortex distinguishes schizophrenia from bipolar disorder.
    Selemon LD; Rajkowska G
    Curr Mol Med; 2003 Aug; 3(5):427-36. PubMed ID: 12942996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression.
    Kristiansen LV; Meador-Woodruff JH
    Schizophr Res; 2005 Oct; 78(1):87-93. PubMed ID: 16023328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.